RWE Study – Page 13 – Healthcare Data News

C-Path and NICHD to Share Real-world Data to Advance Neonatal Drug Development

TUCSON, Ariz., Dec. 1, 2021 — Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) today announced a seminal data-sharing collaboration with the Eunice Kennedy Shriver National Institute of Child Health and...

December 2, 2021October 4, 2022 Industry News Marketing RWE Study Survey

Landscape of AI Technology Companies in Real World Studies Industry

This report aims to guide readers through modern drug development and evidence-based medicine, giving a deep understanding of policies, the landscape of leading companies and their services, and new growth...

December 2, 2021 Academic Collaborations Competitor News COVID-19 RWE Study

When it comes to PE, racial disparities exist among COVID-19 patients

By AuntMinnie.com staff writers December 1, 2021 — Racial disparities exist when it comes to pulmonary embolism (PE) caused by COVID-19, according to research presented Wednesday afternoon at the RSNA 2021...

December 1, 2021December 1, 2021 Academic Europe Industry News International Pharma RWE Study

The Lancet Regional Health – Europe publishes ‘real-world evidence’ from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ — ALK (ALKB: DC) (OMX: ALK B) (OMX: AKABY) (OMX: AKBLF) today announced that results from the REACT study, a large retrospective real-world study comprising more...

November 30, 2021December 1, 2021 Competitor News COVID-19 RWE Study

nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis

CAMBRIDGE, Mass., Nov. 30, 2021 /PRNewswire/ — nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the...

November 29, 2021December 1, 2021 Industry News Oncology RWE Study

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020

Bhakti Arondekar, Mei Sheng Duh, Rachel H. Bhak, Maral DerSarkissian, Lynn Huynh, Kelsey Wang, John Wojciehowski, Melody Wu, Bryon Wornson, Alexander Niyazov and George D. DemetriDOI: 10.1158/1078-0432.CCR-21-2639 Article Figures & Data Info & Metrics PDF Abstract Real-world evidence (RWE) has garnered great interest to support registration of new therapies and label expansions by...

November 9, 2021December 1, 2021 Competitor News COVID-19 Oncology Product Updates RWE Study

Introducing the Truveta Platform: Unprecedented De-Identified Health Data Refreshed Daily with New COVID-19 Insights

TUESDAY NOVEMBER 9TH, 2021 Amongst vaccinated Americans, Moderna recipients experience most adverse events and Johnson & Johnson recipients have most hospitalizations REDMOND, Wash. – November 9, 2021 – Truveta, the...

November 5, 2021January 5, 2022 Government/Regulatory Industry News Oncology RWE Study

Clinical Cancer Research Publishes a Systematic Review of Regulatory Real-World Evidence in Successful Oncology Product Approvals

BOSTON, Nov. 5, 2021 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, today announced the publication of research examining the US Food and Drug...

October 11, 2021December 1, 2021 China Industry News International RWE Study

A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China

Neal E. Storm DRSc, MS, MBA, RAC, Wen Chang PhD, Tzu-Chieh Lin PhD, Jeff L. Lange PhD, Brian Bradbury DSc, Cathy W. Critchlow PhD & Steven K. Galson MD, MPH Therapeutic...

October 1, 2021December 1, 2021 Industry News RWE Study

Nationwide EHR-linked database of real-world patients aids rheumatologists

Not too long ago, Hauppauge, New York-based United Rheumatology had limited opportunities to directly capture the experience of patients across the country to answer important clinical questions. THE PROBLEM Although...